about
Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity programPrevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community healthThe burden of hepatitis C in the United States.Social determinants and the health of drug users: socioeconomic status, homelessness, and incarcerationHIV and incarceration: prisons and detention.Palliative interventional pulmonology procedures in the incarcerated population with cancer: a case series.Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008.Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--IranDesign and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).Attitudes and practices regarding the use of methadone in US state and federal prisonsUsing a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients.The relationship between addiction and socio-demographic characteristics of Iranian newcomer prisoners.Factors related to correctional facility incarceration among active injection drug users in Baltimore, MDTreatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak.Linkage with methadone treatment upon release from incarceration: a promising opportunity.Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis
P2860
Q24676385-92552863-ED17-498F-8A6C-DE4B2CE5618DQ33840231-5CF63EEB-010F-4D5E-ADA9-3D69F998974BQ34289653-1D92F0CC-6DC9-4729-ACF4-D072F21A8BD4Q34984035-96A20359-C2AF-4E49-B7EA-89A9BCCA8904Q34999738-E10457D8-62C5-456B-9117-6888038C19D0Q35068308-E0B45D0E-5698-4E82-BFFF-95801CB9A39FQ35205704-1CD9B3A4-F105-4948-8E2E-BA0FE3BD4FD0Q35724483-4EABF581-EF7A-4343-82BD-03255449C029Q35851167-B606200A-6813-4553-A2FD-3E68B76999C0Q36144776-9A709E2A-4258-4806-8AD4-37304262A686Q36272833-AFC6493E-7CA8-4A13-90A2-D29370406AEDQ36273875-4C2C5901-480E-4591-A6CE-2C1C3BEBF76FQ36364200-94B889C8-0A3E-4A0E-9EEE-BB601A59A695Q36779598-D2A93A8A-4B0F-4404-944B-465E9358D32BQ37415184-176E48B6-5975-41B9-A20E-EF02F73E2573Q42984882-7211A625-D5E7-4CF1-B38E-42A2E169461CQ42990208-57A6669E-B353-4440-9424-595DB9A606E7Q43034999-63008E7E-EE48-471A-96A1-5F4BBD55E4E0Q44183258-15060095-282A-47BB-A1D7-4D388DF6334CQ44458324-BED955AB-0469-43C9-93DB-26BD4462E7A6Q57109962-BFCEDAE9-8663-4897-A4E2-3F3433B6EC66
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Hepatitis C and the correctional population.
@en
type
label
Hepatitis C and the correctional population.
@en
prefLabel
Hepatitis C and the correctional population.
@en
P1476
Hepatitis C and the correctional population.
@en
P2093
R W Reindollar
P304
P356
10.1016/S0002-9343(99)00394-0
P407
P577
1999-12-01T00:00:00Z